People: Arena Pharmaceuticals Inc (ARNA.OQ)
23 Apr 2019
Ms. Jennifer Jarrett is a Director of the Company. Ms. Jarrett has served as the Chief Business Officer and Chief Financial Officer of Arcus Biosciences, a biotechnology company developing next generation cancer immunotherapies, since March 2017. Prior to Arcus, Ms. Jarrett was the Chief Financial Officer of Medivation from April 2016 to October 2016, when it was acquired by Pfizer. Prior to Medivation, Ms. Jarrett spent 20 years in investment banking, including as Managing Director at Citigroup from July 2010 to March 2016, where she was responsible for managing their West Coast life sciences investment banking practice, and, before that, at Credit Suisse and Donaldson, Lufkin & Jenrette. During her tenure as an investment banker, Ms. Jarrett covered biotechnology and pharmaceutical companies, primarily in the Bay Area. In 2014, Ms. Jarrett was named one of the Most Influential Women in Bay Area Business by San Francisco Business Times. Ms. Jarrett has a BA in Economics from Dartmouth College and an MBA from Stanford Graduate School of Business.
|Total Annual Compensation, USD||--|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||213,988|
|Fiscal Year Total, USD||213,988|